Read our most recent articles and announcements
Solarvest has advanced on many fronts since the recent financing. The focus has been on expansion of the product line for white label sales to large and influential companies based in the USA. The initial response has been positive as many companies are formulating with our ingredient and assessing our value-added products.
Solarvest has entered into an advertising and investor awareness campaign with Investing News Network (INN) dedicated to providing independent news and education to investor.
Eversea Inc., has entered into a contractual agreement with Canada’s Smartest Kitchen to develop a formulation for a nutritional-enhancing ingredient based on Eversea’s patented organic DHA powder. This mixture can be used by companies who are producing plant-based seafoods which require Omega-3s to compete in the fish and shellfish marketplace.
Solarvest has added key personnel as part of its operational expansion program to increase production volumes.
Eversea has signed an agreement with MRF Associates Inc. to represent the company in Brazil. Under the agreement MRF will use its extensive background and relationships to introduce SVS Organic Omega-3 products and ingredients into the Brazil marketplace.
Solarvest has been granted patents in Australia and India. The intellectual property protection concentrates on the production of algal biomass, algal cell cultures, lipid compounds, and compositions thereof, including fatty acids, carotenoids and fat soluble vitamins.
Solarvest has closed a private placement through the issuance of 9,189,147 units (a “Unit”) for gross proceeds of $2,297,286. The placement closed in two tranches: 3,465,448 Units were issued on March 26th and 5,723,699 Units were issued on April 16th, 2021.
Solarvest and Scoular are exploring a potential business relationship related to developing a sustainable supply of Omega-3 fatty acids, a globally important and limited resource, through a non-binding development program. The goal of the program is to develop protocols and process data for the efficient production of commercial volumes of Omega-3 fatty acids.
Solarvest announces a non-brokered private placement, pursuant to which the Company intends to raise gross proceeds of up to $2,000,000 through the issuance of up to 8,000,000 Units.